Please login to the form below

Mundipharma

This page shows the latest Mundipharma news and features for those working in and with pharma, biotech and healthcare.

Mundipharma and Kings College London both won a Gold and a Silver.

Havas Lynx Group scoops nine Golds at PM Society Awards

Other Gold winners included Aspen, Boeringher Ingelheim, Galderma, Johnson &Johnson, Mundipharma, Napp, Novartis, PTC Therapeutics, Shire, Teva, Tillotts Pharma and ViiV. ... Craft Award for Interactive Communications: Havas Lynx for Teva Pharmaceuticals.
Daily Brief: European approvals for BMS' Opdivo, Aegerion's lipodystrophy treatment, Pfizer's biosimilar and Xeljanz

GlobalData predicts Trazimera can earn $9m in its first year, far behind the forecast 12 month totals for Celltrion and Mundipharma’s Herzuma ($59m), Amgen’s Kanjinti ($33m), and Samsung Bioepsis
Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down

period. A number of biosimilar versions of the drug hit European markets last year, including Celltrion's Truxima, (pictured), marketed by Mundipharma and other firms across the region, and this year
Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

Mundipharma has strengthened its partnership with biopharmaceutical group Celltrion Healthcare by securing rights to its trastuzumab biosimilar. ... As per terms of the deal, Mundipharma - a global network of privately owned independent companies - has
Roche faces biosimilar blitz in 2018

Novartis’ unit Sandoz and Celltrion/Mundipharma’s Truxima have also claimed a European approval for its biosimilar versions of Roche’s immunotherapy drug MabThera (rituximab).

More from news
Approximately 9 fully matching, plus 46 partially matching documents found.

Pharma deals continue to slide

Finally it is always encouraging to see medium size companies like Mundipharma and Jazz finding and licensing new product opportunities. ... Mundipharma built its oncology franchise following the acquisition of an old anti-cancer drug and the deal to
When science is not enough

Mundipharma’s Will Dunlop on a new framework to guide development programmes to a better destination. ... programme,” says Will Dunlop, head of market access for Mundipharma International, who has been developing the project over the last five years.
Deal Watch October 2016

For example in Europe both Pfizer (Hospira) in 2009 and Mundipharma in 2014 have rights to Celltrion's infliximab.
Biosimilars - the same, but different?

This first infliximab biosimilar was developed and manufactured by Celltrion and is marketed by various partners, notably Hospira under the brand name Inflectra and Mundipharma as Remsima.
Deal Watch table for January 2015

Divestment of US rights. 1, 050. Esteve/ Mundipharma. Discovery and development of next generation pain products including E-52862 in P2 for neuropathic pain.

More from intelligence
Approximately 2 fully matching, plus 7 partially matching documents found.

New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics

Latest movers in pharma. Mundipharma hires new SVP business development and strategic partnerships. ... Mundipharma has named Marco Cerato as its senior vice president, business development and strategic partnerships.
Mundipharma appoints Dr Alberto Martinez as president and CEO

His new role will see him take responsibility for strengthening Mundipharma’s network in Europe and focus on its alliances. ... Prior to his time at Mundipharma, he served Napp Pharmaceuticals and Janssen in various capacities.
Mundipharma appoints chief information officer

His new role will see him take responsibility for the IT services provided to Mundipharma’s global network of associated companies. ... My goal is to ensure that the Mundipharma network has the technology support it needs to lead the charge in pharma
Hywel Day joins Napp Pharmaceuticals

Moves from Mundipharma to take up managing director role. Napp Pharmaceuticals has appointed Hywel Day as its new managing director. ... It’s a return to Napp for Day, who spent 10 years at Napp from 2003, before moving to Mundipharma.
Napp names new managing director

Alberto Martinez joins from Mundipharma. UK-based Napp Pharmaceuticals has appointed Alberto Martinez as the company's new managing director. ... Martinez's previous experience includes time as marketing manager at Mundipharma's international operations

More from appointments
Approximately 2 fully matching, plus 6 partially matching documents found.

Research conducted by Research Partnership published in leading medical journal

Commissioned by Mundipharma, the paper is titled ‘Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral
HAVAS Just::

Abbvie. AstraZeneca. Caris Life Sciences. Lilly. Meningitis Trust. Mundipharma. Napp Pharmaceuticals.
Malcolm Badger joins emotive as Creative Director

at global and local affiliate level for clients such as Merck Serono, Lundbeck, Pfizer and MundiPharma.
Lucid Group Communications Limited

Leo. Mead Johnson Nutrition. Mundipharma. Novartis. Pfizer. Regeneron.
Weber Shandwick

Eli Lilly &Co. Genzyme. GlaxoSmithKline. ICON. Johnson &Johnson. Mundipharma. Nike Foundation.